(Q35153748)

6 August 2017

SPECIFIC ANTIPNEUMOCOCCAL IMMUNITY IN RELATION TO THE CHEMOTHERAPY OF PNEUMONIA. (English)

1 reference

6 August 2017

1 reference

1 reference

Tillett WS

1

1 reference

6 August 2017

Cambier MJ

series ordinal

2

1 reference

6 August 2017

Dunn H

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 September 1942

1 reference

Journal of Clinical Investigation

6 August 2017

1 reference

6 August 2017

21

1 reference

6 August 2017

511-523

1 reference

6 August 2017

5

1 reference

ANTIBODY FORMATION IN CASES OF LOBAR PNEUMONIA TREATED WITH SULFATHIAZOLE.

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=435168

PubMed Central

reference URL

ANTIBODY FORMATION IN CASES OF LOBAR PNEUMONIA TREATED WITH SULFAPYRIDINE.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=435168

PubMed Central

reference URL

IMMUNOLOGICAL STUDIES ON PATIENTS WITH PNEUMOCOCCIC PNEUMONIA TREATED WITH SULFAPYRIDINE.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=435168

PubMed Central

reference URL

13 July 2018

Identifiers

DOI

10.1172/JCI101328

1 reference

6 August 2017

1 reference

6 August 2017

1 reference